18-Mar-15 India's drug regulatory authority plans to publish a revised National List of Essential Medicines in 2015 - long overdue as it was originally prepared in 2011 and has attracted criticism for repeated delays. The revision is very much necessary as the list is linked to regulating the price of medicines. [image: Maps Of India]

13-Mar-15 China will name and shame medical equipment manufacturers caught evading official procedures while selling products overseas. Companies found to have applied for export certificates with fabricated data or other fraudulent methods will be banned from re-applying for two years. [image: China Business Review]

13-Mar-15 China had more than 18,500 drugs waiting for approval at the end of 2014, up by a third from 2013, the official Center for Drug Evaluation has said, data that seems to support industry concern that it is becoming more difficult to get medicines approved in the China market. [image: AFP_Anthony Wallace]

24-Feb-15 China's National Health & Family Planning Commission (NHFPC) Work Plan states that, in specific years during 2015-2017, 40+ listed large medical institutions will be inspected by regulators. Although larger medical institutions are the focus of this inspection campaign, the NHFPC Work Plan is aimed at sending a broader message to institutions and businesses in the healthcare sector throughout China. [image: Healthcare Law Insights]

20-Feb-15 Columbia has announced new price regulations for medical devices from Mar-15. Medicated coronary stents will be the first device to be affected, followed by cochlear implants, hearing aids and orthopedic devices. The move is expected to result in 36% reduction in prices and USD14 billion in annual savings for the national health system. [image: mashmedical]